Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

1 résultats trouvés

Development of oncolytic HSV-1 to activate necroptosis induced anticancer immunity against glioblastoma

This research uses engineered oncolytic viruses that preferentially infect cancer cells as a platform to deliver a new treatment strategy for glioblastoma.


TYPE DE SUBVENTION
Autres
Domaine de recherche
Le cancer
Concours
Bourses de recherche doctorale du SRC
Province
Ontario
DATE DE DÉBUT
2026